| 查看: 313 | 回复: 0 | |||
jlucuixy银虫 (初入文坛)
|
[求助]
求助翻译，万分感谢@药物分析
|
|
With AOAC guidance under a contract with Elanco Animal Health, a Division of Eli Lilly and Company, candidate methods have been recommended for the second set of priority compounds: nicarbazin, apramycin, and avilamycin (candidate methods for the original compounds tylosin, tilmicosin, narasin, monensin, and ractopamine were recommended in June 2009; see November/December 2010 issue of ILM for an update on these compounds). On December 7-9, 2010, at AOAC headquarters in Gaithersburg, Maryland, USA, expert review panels (ERPs) evaluated 30 of the most promising and potential candidate methods for nicarbazin, apramycin, and avilamycin analysis in animal tissues. Fitness-for-purpose statements were meticulously developed against which candidate methods were reviewed. [ Last edited by jlucuixy on 2011-5-20 at 13:34 ] |
回复此楼» 猜你喜欢
售SCI一区文章，我:8O5.5.1.O5.4,科目全,可伽急
已经有3人回复
-
售SCI一区文章，我:8.O.551.O.5.4,科目全,可伽急
已经有3人回复
-
售SCI一区T0P文章，我:8O.55.1.O.5.4,科目齐全,可+急
已经有3人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有3人回复
-
售SCI一区文章，我:8.O.551.O.5.4,科目全,可伽急
已经有3人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有3人回复
-
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有6人回复
-
售一区SCI文章T0P，我:8O.551.O54,科目全,可十急
已经有9人回复
-
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有3人回复
-
考博求助
已经有3人回复
10